| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |